Loerop James

CIK 00017815492 companiesWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001781549

Recent Transactions

50 trades

Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2026-01-02+18,150→ 161,212 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2026-01-02−18,150→ 18,700 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2026-01-02$2.88/sh−6,171→ 155,041 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-12-31+73,750→ 177,056 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-12-31−73,750→ 0 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-12-31$3.01/sh−33,994→ 143,062 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-02-03+83,500→ 83,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2025-02-03+292,300→ 292,300 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-02-01−14,750→ 44,250 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-02-01−11,250→ 11,250 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01+14,750→ 118,753 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01+7,500→ 104,003 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01$2.48/sh−15,447→ 103,306 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-02-01+11,250→ 96,503 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Resticted Stock Units
2025-02-01−7,500→ 15,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-01-02+55,000→ 55,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-02+18,150→ 93,828 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-01-02$2.48/sh−8,575→ 85,253 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-01-02−18,150→ 36,850 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-31$2.48/sh−32,089→ 75,678 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-12-31−73,750→ 73,750 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-12-31+73,750→ 107,767 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-02-01+11,250→ 32,938 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-02-01$1.20/sh−2,568→ 34,017 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2024-02-01+206,500→ 206,500 total
Tax Payment
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-02-01$1.20/sh−3,853→ 29,085 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-02-01+7,500→ 36,585 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-02-01−11,250→ 22,500 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Unit
2024-02-01−7,500→ 22,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-02-01+147,500→ 147,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-02-01+59,000→ 59,000 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-08-28$6.80/sh+14,705→ 21,688 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-02-08$13.89/sh−4,267→ 6,983 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-02-01+11,250→ 11,250 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2023-02-01+105,000→ 105,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-02-01−11,250→ 33,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-02-01+30,000→ 30,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-02-01+45,000→ 45,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2022-02-01+155,000→ 155,000 total
Tax Payment
Anika Therapeutics, Inc.$ANIK
Common Stock
2021-07-08$43.24/sh−731→ 5,592 total
Exercise/Conversion
Anika Therapeutics, Inc.$ANIK
Restricted Stock Unit
2021-07-08+3,000→ 3,000 total
Exercise/Conversion
Anika Therapeutics, Inc.$ANIK
Common Stock
2021-07-08+3,000→ 6,323 total
Award
Anika Therapeutics, Inc.$ANIK
Stock Option (Right to Buy)
2021-03-09+16,802→ 16,802 total
Award
Anika Therapeutics, Inc.$ANIK
Restricted Stock Unit
2021-03-09+6,705→ 6,705 total
Exercise/Conversion
Anika Therapeutics, Inc.$ANIK
Common Stock
2021-02-25+1,567→ 3,323 total
Exercise/Conversion
Anika Therapeutics, Inc.$ANIK
Restricted Stock Unit
2021-02-25−1,567→ 3,133 total
Sale
Anika Therapeutics, Inc.$ANIK
Common Stock
2020-07-09$35.15/sh−1,244→ 1,756 total
Award
Anika Therapeutics, Inc.$ANIK
Common Stock
2020-07-08+3,000→ 3,000 total
Award
Anika Therapeutics, Inc.$ANIK
Restricted Stock Unit
2020-02-25+4,700→ 4,700 total
Award
Anika Therapeutics, Inc.$ANIK
Stock Option (Right to Buy)
2019-07-08+27,000→ 27,000 total

Companies

Recent Filings

Address

C/O ACLARIS THERAPEUTICS, INC. 701 LEE ROAD, SUITE 103

WAYNE, PA, 19087

View on SEC.gov